Quantifying the economic effects of ravulizumab versus eculizumab treatment in patients with atypical hemolytic uremic syndrome
Author:
Affiliation:
1. Department of Community Health and Epidemiology, Dalhousie University, Halifax, NS, Canada
2. Alexion, AstraZeneca Rare Disease, Boston, MA, USA
3. Broadstreet Health Economics and Outcomes Research, Vancouver, BC, Canada
Funder
Alexion, AstraZeneca Rare Disease
Publisher
Informa UK Limited
Subject
Health Policy
Link
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2027706
Reference45 articles.
1. Cancer across the ages: a narrative review of caregiver burden for patients of all ages
2. Measuring the Caregiver Burden of Caring for Community-Residing People with Alzheimer’s Disease
3. The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries – Study Design and Baseline Findings
4. A rare disease patient/caregiver perspective on fair pricing and access to gene-based therapies
5. Cost-of-Illness in Rare Diseases
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials;Kidney Medicine;2024-08
2. Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data;BMC Nephrology;2024-06-19
3. Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature;Expert Review of Hematology;2024-06-12
4. Eculizumab Versus Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome: A Systematic Review;Cureus;2023-09-29
5. Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome;Journal of Comparative Effectiveness Research;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3